Bank of America
SBFMW

Bank of America’s Sunshine Biopharma Inc Warrant SBFMW Stock Holding History

Bank of America’s Portfolio SBFMW Stock Details SBFMW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200
Closed -$30 – 8125
2023
Q4 		$30 Buy
200
+100
+100% +$22 ﹤0.01% 7588
2023
Q3 		$22 Sell
100
-200
-67% -$62 ﹤0.01% 7567
2023
Q2 		$113 Buy
300
+200
+200% +$90 ﹤0.01% 7416
2023
Q1 		$50 Hold
100
– – ﹤0.01% 7522
2022
Q4 		$33 Hold
100
– – ﹤0.01% 7879
2022
Q3 		$0 Hold
100
– – ﹤0.01% 8151
2022
Q2 		$0 Buy
+100
New +$177 ﹤0.01% 8330

Other funds holding SBFMW

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America's SBFMW Position: Q1 2024 in Review

Bank of America sold out of Sunshine Biopharma Inc Warrant (SBFMW) in Q1 2024, closing a stake of 200 shares — an estimated $30 sold.

Bank of America first reported a position in SBFMW in Q2 2022 and held it in 7 quarters. The position peaked at $113 in Q2 2023. 3 funds tracked by Wall St. Rank hold SBFMW as of Q1 2024.

  • Bank of America reported no remaining Sunshine Biopharma Inc Warrant position as of Q1 2024 after selling out during the quarter.
  • Bank of America sold 200 Sunshine Biopharma Inc Warrant shares in Q1 2024, an estimated $30.
  • Bank of America first reported a position in Sunshine Biopharma Inc Warrant in Q2 2022 and held it in 7 quarters.
  • Bank of America's Sunshine Biopharma Inc Warrant position peaked at $113 in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Sunshine Biopharma Inc Warrant as of Q1 2024.

Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.